Cayenne Medical Launches CrossFix™ System for Repair of Meniscal Tears
Next Generation Technology Offers Surgeons Benefits of Both Open and Arthroscopic Procedures
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Cayenne Medical, Inc., a privately held sports medicine company based in Scottsdale, announced the commercial launch of its CrossFix™ System for the repair of meniscal tears at the American Orthopaedic Society for Sports Medicine (AOSSM) annual meeting in Keystone, Colorado last week.
The CrossFix™ system offers surgeons the benefits of both open suturing and arthroscopic meniscal repair. The technology replicates results from “gold standard” open suturing techniques but through a faster and less invasive all-inside method. Unlike traditional all-inside meniscal repair devices, the CrossFix™ system leaves no plastic implants behind, thereby reducing risk of injury over time.
“CrossFix™ is a leap forward for all-inside meniscal repair devices,” said Louis Rizio, M.D., of Sports Medicine & Orthopaedic Center in Livingston, New Jersey, one of the first surgeons in the country to utilize the CrossFix™ system. “CrossFix™ replicates the inside-out suture repair well and minimizes time and morbidity associated with inside-out repairs. The sophistication of this device is in its simplicity!”
The CrossFix™ system is a suture only device that creates a 3mm mattress stitch for a fast, strong, and reliable all-inside meniscal repair. The dual needle design instantly deploys a horizontal or vertical mattress with a pre-tied sliding knot through a single insertion into the meniscus. The device includes an incorporated cannula and depth limiter that controls needle penetration, reducing the risk of neurovascular injury. The repair is biomechanically strong with pull-out forces equal to open suture techniques*. The CrossFix™ system is fast and easy to use, offering surgeons reliable and reproducible patient outcomes.
After using the CrossFix™ system clinically, Kenneth D. Montgomery, MD, of Tri-County Orthopaedic & Sports Medicine in Morristown, New Jersey, reported that, “By inserting both needles at the same time, there is never a problem with suture management, making the repair process as simple as pulling a trigger.”
“We are extremely pleased with the warm reception we received from surgeons at the AOSSM meeting,” said James W. Hart, President and CEO of Cayenne Medical. “With our existing AperFix® technology, Cayenne has already made inroads toward a new standard of care for ACL fixation. Now with CrossFix™, we are responding to an unmet need in the meniscal repair market.”
For more information on Cayenne Medical’s CrossFix™ system, please visit http://www.cayennemedical.com/products/crossfix/.
About Cayenne Medical, Inc.:
Based in Scottsdale, Arizona, Cayenne Medical is a privately held medical device company defining new technology for the soft tissue reconstruction segment of the sports medicine market. The company was founded in 2005 and is focused on leading the transformation of traditional ACL and meniscal repair procedures by applying advanced technology through minimally invasive techniques. For more information, go to www.cayennemedical.com.
* Data on file
Contacts
For Cayenne Medical, Inc.
Paul Williams
949-916-6880
medialine2@aol.com
No comments:
Post a Comment